ATE470435T1 - Verfahren zur auswahl von kationischen oder anionischen liposomen zur behandlung einer schleimhautmembran und diese enthaltendes set - Google Patents

Verfahren zur auswahl von kationischen oder anionischen liposomen zur behandlung einer schleimhautmembran und diese enthaltendes set

Info

Publication number
ATE470435T1
ATE470435T1 AT04799314T AT04799314T ATE470435T1 AT E470435 T1 ATE470435 T1 AT E470435T1 AT 04799314 T AT04799314 T AT 04799314T AT 04799314 T AT04799314 T AT 04799314T AT E470435 T1 ATE470435 T1 AT E470435T1
Authority
AT
Austria
Prior art keywords
mucosa
treatment
charged lipid
disorder
medicament
Prior art date
Application number
AT04799314T
Other languages
English (en)
Inventor
Yechezkel Barenholz
Abraham Rubinstein
Tareq Jubeh
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Application granted granted Critical
Publication of ATE470435T1 publication Critical patent/ATE470435T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
AT04799314T 2003-11-03 2004-11-03 Verfahren zur auswahl von kationischen oder anionischen liposomen zur behandlung einer schleimhautmembran und diese enthaltendes set ATE470435T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51631603P 2003-11-03 2003-11-03
PCT/IL2004/001005 WO2005041932A2 (en) 2003-11-03 2004-11-03 Method for selecting cationic or anionic liposomes for treatment of a mucosa membrane, and kit comprising the same

Publications (1)

Publication Number Publication Date
ATE470435T1 true ATE470435T1 (de) 2010-06-15

Family

ID=34549524

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04799314T ATE470435T1 (de) 2003-11-03 2004-11-03 Verfahren zur auswahl von kationischen oder anionischen liposomen zur behandlung einer schleimhautmembran und diese enthaltendes set

Country Status (5)

Country Link
US (1) US20070212403A1 (de)
EP (1) EP1694298B1 (de)
AT (1) ATE470435T1 (de)
DE (1) DE602004027655D1 (de)
WO (1) WO2005041932A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1617808A4 (de) 2003-04-25 2011-11-02 Penn State Res Found Verfahren und system für die systemische abgabe von wachstumshemmenden von lipiden stammenden bioaktiven verbindungen
US20070087045A1 (en) * 2005-10-14 2007-04-19 Industrial Technology Research Institute Lipid carrier and method of preparing the same
WO2008087803A1 (ja) * 2007-01-16 2008-07-24 Hokkaido University 抗酸化成分を封入したイオントフォレーシス用リポソーム製剤
WO2010074172A1 (ja) * 2008-12-24 2010-07-01 株式会社バイオメッドコア リポソームの製造方法ならびにコレステロール溶解方法
CA2827118A1 (en) * 2011-02-15 2012-08-23 Merrimack Pharmaceuticals, Inc. Compositions and methods for delivering nucleic acid to a cell
CN102192978B (zh) * 2011-03-15 2013-09-04 中国科学院武汉病毒研究所 评价作用于体内粘膜的药物和外源物安全性的方法及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0714865B2 (ja) * 1986-10-28 1995-02-22 武田薬品工業株式会社 リポソ−ム製剤およびその製造法
US4918063A (en) * 1987-02-17 1990-04-17 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
WO1993014744A1 (en) * 1992-02-04 1993-08-05 Chiron Corporation Non-toxic lipid vaccine formulations
US20020039556A1 (en) * 1995-09-27 2002-04-04 Kari Dyvik Stabilised phospholipid compositions
AU753196B2 (en) * 1998-02-09 2002-10-10 Bracco Research S.A. Targeted delivery of biologically active media
US6872406B2 (en) * 2000-02-11 2005-03-29 Children's Hospital Research Foundation Fusogenic properties of saposin C and related proteins and polypeptides for application to transmembrane drug delivery systems
US6616944B2 (en) * 2000-03-08 2003-09-09 Medinnova Gesellschaft Fur Medizinsche Innovationen Aus Adkademischer Forschung Mbh Self-assembling colloidal carriers for protein delivery
GB0111279D0 (en) * 2001-05-10 2001-06-27 Nycomed Imaging As Radiolabelled liposomes
DE60238958D1 (de) * 2001-06-29 2011-02-24 Chugai Pharmaceutical Co Ltd Krebsimpfstoff mit einem Krebs-Antigen auf Grundlage des Produkts aus dem Tumorunterdrückungsgen WT1 und einem kationischen Liposom

Also Published As

Publication number Publication date
US20070212403A1 (en) 2007-09-13
WO2005041932A3 (en) 2005-06-02
WO2005041932A2 (en) 2005-05-12
DE602004027655D1 (de) 2010-07-22
EP1694298B1 (de) 2010-06-09
EP1694298A2 (de) 2006-08-30

Similar Documents

Publication Publication Date Title
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
ATE309802T1 (de) Verwendung von cyclopamine zur behandlung von psoriasis und anderen hauterkrankungen
ATE468137T1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
AR066292A1 (es) Tratamiento para la degeneracion macular relacionada con el envejecimiento utilizando inhibidores de factor d complementario
DE69631605D1 (de) Verfahren zur verringerung und zur erhaltung von verringerten blutspiegeln von lipiden mittels zubereitungen von ob-proteinen
CY1107780T1 (el) Μεθοδος για τη θεραπεια οφθαλμικων νεοαγγειακων ασθενειων
BR0111591A (pt) Compostos, composição farmacêutica, e, métodos para elevar o nìvel de plasma do hormÈnio de crescimento em um mamìfero, para o tratamento de deficiência da secreção do hormÈnio de crescimento, para o tratamento do retardo do crescimento em crianças, para o tratamento de distúrbios metabólicos associados com a deficiência da secreção do hormÈnio de crescimento, em particular em pacientes idosos, e para promover a cura de ferimentos, recupeção de cirurgia ou recuperação de doenças debilitantes
HUP0400548A2 (hu) Belső szemnyomást csökkentő hatóanyag-kombinációk alkalmazása glaukoma kezelésére szolgáló gyógyszerkészítmények előállítására
Yang et al. Sihler-stain study of buccal nerve distribution and its clinical implications
Motta et al. Aesthetic restoration of deciduous anterior teeth after removal of carious tissue with papacarie®
MXPA05012392A (es) Tratamientos de ansiedad con ziprasidona.
ATE260282T1 (de) Aromatische ester von camptothecinen und verfahren zur behandlung von krebserkrankungen
ATE470435T1 (de) Verfahren zur auswahl von kationischen oder anionischen liposomen zur behandlung einer schleimhautmembran und diese enthaltendes set
DE60140960D1 (de) Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
ATE398456T1 (de) Verwendung von negativ-geladenen phospholipiden zur herstellung eines medikaments zur behandlung und/oder vorbeugung von makuladegeneration
BRPI0415215A (pt) aplicação de um polifenol para o tratamento de uma lesão cancerosa ou pré-cancerosa da pele
MX2023002350A (es) Composiciones y metodos para mejorar enfermedades y trastornos neurologicos.
Manzon et al. Injuries on a skull from the Ancient Bronze Age (Ballabio, Lecco, Italy): a natural or an anthropic origin?
DE69924146D1 (de) Etherlysophospholipide zur behandlung von chronischen entzündlichen erkrankungen
ATE338558T1 (de) Verwendung von phosphoglyzeriden enthaltend phosphoglycero-ether zur behandlung neurodegenerativer erkrankungen in geistig schwer behinderten kindern
DE602004030661D1 (de) Verwendung von kahalalide verbindungen zur herstellung eines arzneimittels zur behandlung von psoriasis
EP1365771A4 (de) Verfahren zur behandlung bestimmter augenkrankheiten
BR0308040A (pt) Composições farmacêuticas e cosméticas compreendendo plgf-1
Teng et al. Tumor arising in the right sciatic nerve of a 58-year-old man.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties